Last reviewed · How we verify
Nicalex (aluminium nicotinate)
Nicalex (generic name: aluminium nicotinate) is a aluminium nicotinate drug. It is currently in unknown development.
Nicalex works by improving blood flow and reducing inflammation in the body.
Nicalex, also known as aluminium nicotinate, is a small molecule drug in the aluminium nicotinate class. Its exact target and mechanism of action are unknown, but it is believed to work by improving blood flow and reducing inflammation. Nicalex is not FDA-approved for any indications, and its commercial status, including patent status and generic availability, is unclear. As a result, key safety considerations and pharmacokinetic properties, such as half-life and bioavailability, are also unknown. Further research is needed to fully understand Nicalex's potential therapeutic applications and risks.
At a glance
| Generic name | aluminium nicotinate |
|---|---|
| Drug class | aluminium nicotinate |
| Therapeutic area | Hematology |
| Phase | unknown |
Mechanism of action
Think of blood flow like a highway system in your body. Nicalex helps to widen and improve the flow of traffic on these highways, allowing oxygen and nutrients to reach your cells more easily. This can help to reduce inflammation and improve overall health.
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne (NA)
- The Effects of Jing-Si Herbal Tea Liquid Packets and Jing-Si Herbal Tang Heng Power Drink (NA)
- Vitamin E Supplementation in Burned Patients (PHASE2,PHASE3)
- Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27) (PHASE1)
- Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60) (PHASE1)
- The Topical Niacin Skin Flush Test in First Episode Psychosis
- Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers (PHASE1)
- Niacin Skin Flush Response in Patients With Schizophrenia (PHASE2,PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nicalex CI brief — competitive landscape report
- Nicalex updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Nicalex
What is Nicalex?
How does Nicalex work?
What is the generic name of Nicalex?
What drug class is Nicalex in?
What development phase is Nicalex in?
Related
- Drug class: All aluminium nicotinate drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Hematology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing